Viracta Therapeutics Reports Q2 2024 Financial Results And Business Update
14 Aug 2024 //
GLOBENEWSWIRE
Viracta Positive Nana-val NAVAL-1 EBV+ PTCL Topline Results
15 Apr 2024 //
GLOBENEWSWIRE
Viracta Therapeutics Announces Orphan Drug Designation Granted
24 Jun 2020 //
PRNEWSWIRE